首页> 美国卫生研究院文献>Yonsei Medical Journal >Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer

【2h】

Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer

机译：转移部位和疼痛对转移性前列腺癌患者去势抵抗和死亡率进展的预后影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo investigate predictors of progression to castration-resistant prostate cancer (CRPC) and cancer-specific mortality (CSM) in patients with metastatic prostate cancer (mPCa).

机译：目的研究转移性前列腺癌（mPCa）患者发展为去势抵抗性前列腺癌（CRPC）和癌症特异性死亡率（CSM）的预测因素。

著录项

期刊名称 Yonsei Medical Journal
作者
Kyo Chul Koo; Sang Un Park; Ki Hong Kim; Koon Ho Rha; Sung Joon Hong; Seung Choul Yang; Byung Ha Chung;
展开▼
作者单位

展开▼
年(卷),期 2015(56),5
年度 2015
页码 1206–1212
总页数 7
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Bone metastasis pain prostate cancer viscera;

机译：骨;转移;疼痛;前列腺癌;内脏;

相似文献

外文文献
中文文献
专利

1. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer [J] . Koo Kyo Chul, Park Sang Un, Kim Ki Hong, Yonsei Medical Journal . 2015,第5期

机译：转移部位和疼痛对转移性前列腺癌患者去势抵抗和死亡率进展的预后影响
2. Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer [J] . Miyake Hideaki, Matsushita Yuto, Watanabe Hiromitsu, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第3期

机译：转移阉割敏感前列腺癌患者阉割抗阉割时间的预后意义
3. Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease. [J] . Dreicer R, Garcia J, Hussain M, Investigational new drugs. . 2011,第6期

机译：前列腺癌中的口服enzastaurin：一项在非转移性去势状态且以多西他赛为基础的化疗治疗去势转移性疾病的PSA进展的患者的两项队列II期试验。
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Relationships between times to testosterone and prostate-specific antigen rises during the first off treatment interval of intermittent androgen deprivation are prognostic for castration-resistance in men with non-metastatic prostate cancer [O] . Kevin F. Kuo, Rachel Hunter-Merrill, Roman Gulati, -1

机译：在非转移性前列腺癌的男性中在第一个非治疗间歇性雄激素剥夺间隔中睾丸激素与前列腺特异性抗原的时间之间的关系预后为去势抵抗
7. Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment [O] . Emmy Boerrigter, Guillemette E. Benoist, Inge M. Oort, 2021

机译：液体活组织检查显示KLK3 mRNA作为患有转移性阉割抗性前列腺癌患者的进展自由存活的预后标志物，该抗前列腺癌进行第一线AbiraTerone醋酸盐和泼尼松治疗

Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅